Effects of arginine vasopressin on human anxiety and associations with sex, dose, and V1a-receptor genotype

R. R. Thompson,D. Price,D. Burris,A. Cloutier,J. K. Rilling
DOI: https://doi.org/10.1007/s00213-024-06551-7
2024-02-16
Psychopharmacology
Abstract:Arginine vasopressin (AVP) has dose- and sex-specific effects on social behavior, and variation in social responses is related to variation in the V1a receptor gene in animals. Whether such complexity also characterizes AVP effects on anxiety in humans, or whether V1a genotype is related to anxiety and/or AVP's ability to affect it, remains to be determined.
pharmacology & pharmacy,neurosciences,psychiatry
What problem does this paper attempt to address?